BR112022020994A2 - Formulações tópicas não aquosas - Google Patents
Formulações tópicas não aquosasInfo
- Publication number
- BR112022020994A2 BR112022020994A2 BR112022020994A BR112022020994A BR112022020994A2 BR 112022020994 A2 BR112022020994 A2 BR 112022020994A2 BR 112022020994 A BR112022020994 A BR 112022020994A BR 112022020994 A BR112022020994 A BR 112022020994A BR 112022020994 A2 BR112022020994 A2 BR 112022020994A2
- Authority
- BR
- Brazil
- Prior art keywords
- formulations
- topical formulations
- aqueous topical
- emulsions
- vitamin
- Prior art date
Links
- 239000012049 topical pharmaceutical composition Substances 0.000 title abstract 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 6
- 238000009472 formulation Methods 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 3
- 229930003268 Vitamin C Natural products 0.000 abstract 3
- 239000000839 emulsion Substances 0.000 abstract 3
- 239000000126 substance Substances 0.000 abstract 3
- 235000019154 vitamin C Nutrition 0.000 abstract 3
- 239000011718 vitamin C Substances 0.000 abstract 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 2
- 230000032683 aging Effects 0.000 abstract 2
- 239000004202 carbamide Substances 0.000 abstract 2
- 239000012141 concentrate Substances 0.000 abstract 2
- 239000002537 cosmetic Substances 0.000 abstract 2
- 239000006071 cream Substances 0.000 abstract 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 abstract 2
- 210000002966 serum Anatomy 0.000 abstract 2
- -1 serums Substances 0.000 abstract 2
- 230000009759 skin aging Effects 0.000 abstract 2
- 230000000087 stabilizing effect Effects 0.000 abstract 1
- 150000005846 sugar alcohols Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
- A61K2800/31—Anhydrous
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
FORMULAÇÕES TÓPICAS NÃO AQUOSAS. A presente divulgação refere-se a várias formulações tópicas não aquosas, que podem ser adaptadas para uso em uma variedade de formas (por exemplo, concentrados, soros, soluções de peeling químico, máscaras de enxágue, cremes, emulsões, etc.) para uso cosmético, para aplicação para tratar condições dermatológicas, e/ou para uso na redução da aparência do envelhecimento cronológico e/ou envelhecimento da pele causado pelo meio ambiente. As formulações tópicas não aquosas desta divulgação incluem: 1) formulações estabilizadoras de vitamina C, 2) formulações de peeling químico de vitamina C, 3) formulações de vitamina C e álcool de açúcar, 4) emulsões de ureia anidra, e 5) formulações de ácido azelaico anidro, que são descritas abaixo com mais detalhes. Essas formulações tópicas podem ser adaptadas para uso em uma variedade de formas (por exemplo, concentrados, soros, soluções de peeling químico, máscaras de enxágue, cremes, emulsões, etc.) para uso cosmético, para aplicação para tratar condições dermatológicas, e/ou para uso na redução da aparência do envelhecimento cronológico e/ou envelhecimento da pele causado pelo meio ambiente.
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063010878P | 2020-04-16 | 2020-04-16 | |
| US202063010881P | 2020-04-16 | 2020-04-16 | |
| US202063010889P | 2020-04-16 | 2020-04-16 | |
| US202063010888P | 2020-04-16 | 2020-04-16 | |
| US202063010884P | 2020-04-16 | 2020-04-16 | |
| PCT/US2021/027832 WO2021212077A2 (en) | 2020-04-16 | 2021-04-16 | Non-aqueous topical formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022020994A2 true BR112022020994A2 (pt) | 2022-12-06 |
Family
ID=78084516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022020994A BR112022020994A2 (pt) | 2020-04-16 | 2021-04-16 | Formulações tópicas não aquosas |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4136056A4 (pt) |
| JP (1) | JP2023522328A (pt) |
| KR (1) | KR20230005221A (pt) |
| CN (1) | CN115697903A (pt) |
| BR (1) | BR112022020994A2 (pt) |
| TW (1) | TW202203912A (pt) |
| WO (1) | WO2021212077A2 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021256054A1 (en) | 2020-04-16 | 2022-11-24 | Baek Clinical Inc. | High-potency vitamin C and sugar alcohol topical formulations |
| CN116710044A (zh) * | 2020-12-31 | 2023-09-05 | 莱雅公司 | 用于护理角蛋白材料的组合物 |
| WO2023069639A1 (en) * | 2021-10-20 | 2023-04-27 | Baek Clinical Inc. | Anhydrous urea emulsions with a retinoid agent |
| CN115887289B (zh) * | 2022-10-27 | 2024-03-08 | 广州百孚润化工有限公司 | 一种保湿组合物、含有该保湿组合物的化妆品及其制备方法 |
| KR102671775B1 (ko) * | 2023-08-30 | 2024-06-03 | 한국콜마주식회사 | 활성화 성분의 역가 유지율과 제형 안정성이 우수한 화장료 조성물 및 상기 화장료 조성물의 제조방법 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05229927A (ja) * | 1992-02-21 | 1993-09-07 | Kao Corp | 美白化粧料 |
| UY24246A1 (es) * | 1995-06-06 | 1996-06-14 | Neutrogena Corp | Vehiculos tropicos que contienen acido azelaico solubilizado y estabilizado |
| US20030180333A1 (en) * | 1997-06-27 | 2003-09-25 | Revlon Consumer Products Corporation | Compositions containing stabilized ascorbic acid and related methods |
| US6020367A (en) * | 1997-12-02 | 2000-02-01 | Avon Products, Inc. | Supersaturated ascorbic acid solutions |
| WO2005070380A1 (en) * | 2004-01-13 | 2005-08-04 | Skinceuticals, Inc. | Stabilized ascorbic acid compositions and methods therefor |
| US20070172436A1 (en) * | 2006-01-23 | 2007-07-26 | Jerry Zhang | Nonaqueous ascorbic acid compositions and methods for preparing same |
| US8568749B2 (en) * | 2009-04-02 | 2013-10-29 | Sesvalia Usa, Llc | Systems and methods for skin rejuvenation |
| WO2017117099A1 (en) * | 2015-12-29 | 2017-07-06 | L'oreal | Stable antioxidant compositions |
| US10149808B2 (en) * | 2016-03-31 | 2018-12-11 | L'oreal | Cosmetic compositions and methods for providing full spectrum photo protection |
| WO2018081779A1 (en) * | 2016-10-31 | 2018-05-03 | Sytheon Limited | Skin enhancing compositions and methods |
| EP3713583A4 (en) * | 2017-11-21 | 2021-06-30 | Topix Pharmaceuticals, Inc. | METHODS AND COMPOSITIONS FOR TREATMENT OF THE SKIN |
| KR20210079321A (ko) * | 2018-10-18 | 2021-06-29 | 백 클리니컬 인크. | 고효능 비타민 c 국소 제형 |
-
2021
- 2021-04-16 JP JP2022562724A patent/JP2023522328A/ja active Pending
- 2021-04-16 CN CN202180036744.7A patent/CN115697903A/zh active Pending
- 2021-04-16 WO PCT/US2021/027832 patent/WO2021212077A2/en active Application Filing
- 2021-04-16 TW TW110113850A patent/TW202203912A/zh unknown
- 2021-04-16 EP EP21788324.8A patent/EP4136056A4/en active Pending
- 2021-04-16 KR KR1020227039937A patent/KR20230005221A/ko unknown
- 2021-04-16 BR BR112022020994A patent/BR112022020994A2/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW202203912A (zh) | 2022-02-01 |
| EP4136056A4 (en) | 2024-09-04 |
| CN115697903A (zh) | 2023-02-03 |
| KR20230005221A (ko) | 2023-01-09 |
| JP2023522328A (ja) | 2023-05-30 |
| WO2021212077A2 (en) | 2021-10-21 |
| EP4136056A2 (en) | 2023-02-22 |
| WO2021212077A3 (en) | 2022-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022020994A2 (pt) | Formulações tópicas não aquosas | |
| Endly et al. | Oily skin: a review of treatment options | |
| US8334413B2 (en) | Topical compositions and methods for epithelial-related conditions | |
| BRPI0700678A (pt) | método para aperfeiçoar comportamentos de sono | |
| BR0015604A (pt) | Método para o tratamento de cicatrizes hipertróficas de modo a reduzir o tamanho e/ou melhorar a aparência das mesmas, composições para tratar condições adversas da pele, e, para reduzir o tamanho e melhorar a aparência de cicatrizes hipertróficas | |
| BR0204271A (pt) | Composição anticaspa, xampu anticaspa, método para redução do prurido do couro cabeludo humano causado pela dermatite seborréica, composição para redução de uma sensação de coceira que ocorre na superfìcie externa da epiderme humana, composição de cuidado pessoal, método para redução de uma sensação de coceira que ocorre na superfìcie externa da epiderme humana | |
| BR0207663A (pt) | Uso de inibidores de egfr naturais para prevenir os efeitos colaterais devido à terapia com retinóides, sabões e outros estìmulos que ativam o receptor do fator de crescimento epidérmico | |
| BR0116369A (pt) | Composto, método para a profilaxia ou o tratamento de uma condição clìnica em um mamìfero, formulação farmacêutica, uso de um composto, e, processo para preparar composto | |
| Campos et al. | Increased glutathione levels contribute to the beneficial effects of hydrogen sulfide and inducible nitric oxide inhibition in allergic lung inflammation | |
| BR112015021124A2 (pt) | solução para acne | |
| CA2579605C (en) | Topical compositions and methods for epithelial-related conditions | |
| ATE67667T1 (de) | Neue topische metronidazol-formulierungen. | |
| AR122420A1 (es) | Formulaciones tópicas no acuosas | |
| DK1635776T5 (da) | Lipidoverf ringsproteinsystemer samt deres kosmetiske dermatologiske anvendelse | |
| ES2137125B1 (es) | La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal. | |
| BR102017003313B1 (pt) | Composição anticaspa e método para a prevenção, redução ou tratamento da caspa | |
| BR112017021950A2 (pt) | combinação de substâncias naturais contendo pelo menos um ácido glicirretínico e pelo menos um guggulsterone assim como seu emprego para aplicações cosméticas | |
| CN105726349A (zh) | 一种具有抑制酪氨酸酶作用的组合物及应用 | |
| MX2024005052A (es) | Composicion farmaceutica y kit que comprende una sustancia inmunomoduladora para tratar enfermedades. | |
| DK1247521T3 (da) | Anvendelse af biguanid- og pyrimidin-derivater til fremstilling af topiske hudplejetilberedninger | |
| ATE516028T1 (de) | Zusammensetzung zur behandlung von hauterkrankungen | |
| BR0303931A (pt) | Composição cosmética/dermatológica de aplicação tópica, géis de esfoliação da pele com bha de potência elevada, composição cosmética/dermatólogica de aplicação tópica de matéria, regime para a esfoliação quìmica da pele e método para melhorar a solubilidade de um (beta)-hidroxiácido (bha) | |
| BR0213235A (pt) | Composição e método de potenciação | |
| BR112023026173A2 (pt) | Composição que compreende cisteína, triglicerídeo de ácido graxo específico e agente redutor adicional | |
| JP2017500360A (ja) | ホウライアオカズラの抽出物の化粧品としての使用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |